Journal of Cancer and Tumor International

  • About
    • About the Journal
    • Submissions & Author Guideline
    • Accepted Papers
    • Editorial Policy
    • Editorial Board Members
    • Reviewers
    • Printed Hard copy
    • Subscription
    • Membership
    • Publication Ethics and Malpractice Statement
    • Digital Archiving
    • Contact
  • Archives
  • Indexing
  • Publication Charge
  • Submission
  • Testimonials
  • Announcements
Advanced Search
  1. Home
  2. Archives
  3. 2020 - Volume 10 [Issue 3]
  4. Original Research Article

Submit Manuscript


Subscription



  • Home Page
  • Author Guidelines
  • Editorial Board Member
  • Editorial Policy
  • Propose a Special Issue
  • Membership

Body Mass Index and Clinical Outcomes in Egyptian Women with Breast Cancer: A Multi-institutional Study

  • Amrou Mamdouh Abdeen Shaaban
  • Ahmed Hassan Abd Aziz
  • Nada Sholkamy
  • Hoda Mokhtar
  • Shimaa Anwer Emam
  • Abeer Hussien Anter

Journal of Cancer and Tumor International, Page 10-17
DOI: 10.9734/jcti/2020/v10i330128
Published: 19 August 2020

  • View Article
  • Download
  • Cite
  • Statistics
  • Share

Abstract


Purpose: The aim of this work was to evaluate the association between body mass index (BMI) and clinical outcomes among Egyptian female breast cancer patients.


Methods: We reviewed the file registry of 629 patients with operable breast cancer regarding age, sex, height, weight, menopausal status, family history of breast cancer, tumor features, TNM arrangement and treatment during the period from January 2006 to December 2012. In our studies, obesity was defined as a BMI of ≥30 kg/m2. The primary objective was to estimate the effect of body mass index on the clinical outcomes of breast cancer patients including DFS and OAS.


Results: A total of 629 patients with a mean age of 51.1 years. Stage III and Stage II presented 52% and 46.6% respectively. Overweight and obese patients represent 60.5% of all patient population. There was no association between tumor stage, grade or menopausal status and BMI. Patients with normal BMI showed a median survival of 95.3 months [CI: 54.6,136.06]. This was significantly higher than overweight and obese patients (p = 0.001). Nearly one-third of patients (29.1%) with normal BMI experienced disease relapse compared to 32.8% for overweight and obese patients, however, this was statistically not significant (0.097).


Conclusion: According to the results of this retrospective study, increased BMI may be associated with less favorable prognosis of breast cancer patients.


Keywords:
  • Breast cancer
  • body mass
  • outcome
  • Full Article - PDF
  • Review History

How to Cite

Shaaban, A. M. A., Aziz, A. H. A., Sholkamy, N., Mokhtar, H., Emam, S. A., & Anter, A. H. (2020). Body Mass Index and Clinical Outcomes in Egyptian Women with Breast Cancer: A Multi-institutional Study. Journal of Cancer and Tumor International, 10(3), 10-17. https://doi.org/10.9734/jcti/2020/v10i330128
  • ACM
  • ACS
  • APA
  • ABNT
  • Chicago
  • Harvard
  • IEEE
  • MLA
  • Turabian
  • Vancouver
  • Abstract View: 135 times
    PDF Download: 4 times

Download Statistics

  • Linkedin
  • Twitter
  • Facebook
  • WhatsApp
  • Telegram
Make a Submission / Login
Information
  • For Readers
  • For Authors
  • For Librarians
Current Issue
  • Atom logo
  • RSS2 logo
  • RSS1 logo


© Copyright 2010-Till Date, Journal of Cancer and Tumor International. All rights reserved.